CJC-1295 With DAC

Premium Growth Hormone Research Peptide

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic peptide designed to stimulate the natural release of growth hormone (GH) from the pituitary gland. It is a modified version of growth hormone-releasing hormone (GHRH) that incorporates DAC technology to significantly extend its half-life in the body.

Due to its prolonged activity, CJC-1295 with DAC has become a widely studied peptide in research involving growth hormone regulation, body composition, recovery, and healthy aging.

Mechanism of Action

CJC-1295 with DAC binds to GHRH receptors in the pituitary gland, stimulating the body’s natural production and release of growth hormone. This may lead to:

• Increased growth hormone secretion.
• Elevated insulin-like growth factor-1 (IGF-1) levels.
• Enhanced protein synthesis.
• Support for tissue repair and recovery.
• Improved metabolic function.
• Support for healthy body composition.

The DAC modification allows the peptide to remain active for an extended period compared to shorter-acting GHRH analogs.

Research Applications

CJC-1295 with DAC has been investigated in:

• Growth hormone deficiency research.
• Healthy aging studies.
• Body composition and fat metabolism research.
• Muscle maintenance and recovery investigations.
• Exercise and performance studies.
• Sleep and recovery research.
• Metabolic health studies.

Potential Effects Observed in Studies

Research has suggested that CJC-1295 with DAC may:

• Increase endogenous growth hormone production.
• Elevate IGF-1 levels.
• Support lean muscle maintenance.
• Promote fat metabolism.
• Enhance recovery from physical stress.
• Improve sleep quality and recovery processes.
• Support overall metabolic health.

Individual responses may vary based on physiology, dosage, and study duration.

Possible Side Effects

Reported side effects may include:

• Injection-site irritation.
• Headache.
• Flushing.
• Fatigue.
• Mild dizziness.
• Water retention.
• Temporary tingling sensations.

Most reported effects are generally mild and transient.

Precautions

• Long-term safety continues to be evaluated in research settings.
• Growth hormone and IGF-1 levels should be monitored when applicable.
• Individuals with endocrine disorders may require additional evaluation.
• Product purity and quality can vary among suppliers.

Storage

• Typically supplied as a lyophilized (freeze-dried) powder.
• Store refrigerated according to manufacturer recommendations.
• Protect from heat, moisture, and direct sunlight.
• Refrigerate after reconstitution.
• Avoid repeated freeze-thaw cycles.

Packaging

Common Product Formats:

• 2 mg vials.
• 5 mg vials.
• 10 mg vials.
• Research-grade peptide formulations.

Summary

CJC-1295 with DAC is a long-acting GHRH analog designed to stimulate natural growth hormone release and increase IGF-1 production. Its extended half-life, achieved through Drug Affinity Complex technology, makes it a prominent research peptide in studies involving growth hormone regulation, recovery, body composition, metabolic health, and healthy aging.